Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Apollo Endosurgery, Inc.
| Metric | Apollo Endosurgery, Inc. Healthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $77M |
| Net income (latest) | −$40M |
| Operating margin | −40.9% |
| Net margin | −51.8% |
| Return on equity | −122.2% |
| Return on assets | −36.1% |
| Return on capital (ROCE) | −44.4% |
| Debt / equity | 2.38× |
| Revenue growth (YoY) | 22.0% |
| Altman Z″ (distress) | -8.28 |
| Accruals / assets | −7.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.